Piramal Enterprises soars on getting nod to raise Rs 750 crore via NCDs
Piramal Enterprises is currently trading at Rs. 977.30, up by 33.65 points or 3.57% from its previous closing of Rs. 943.65 on the BSE.
The scrip opened at Rs. 945.00 and has touched a high and low of Rs. 980.25 and Rs. 945.00 respectively. So far 57214 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1,738.50 on 07-Oct-2021 and a 52 week low of Rs. 900.70 on 20-June-2022.
Last one week high and low of the scrip stood at Rs. 1011.65 and Rs. 937.05 respectively. The current market cap of the company is Rs. 23324.60 crore.
The promoters holding in the company stood at 43.49%, while Institutions and Non-Institutions held 42.67% and 13.83% respectively.
Piramal Enterprises has received approval to raise up to Rs 100 crore along with an option to retain over subscription of up to Rs 650 crore, aggregating up to Rs 750 crore through the issuance of Secured, Rated, Listed, Redeemable, Principal Protected, Market Linked Non-Convertible Debentures (Debentures) on private placement basis. Debentures are proposed to be listed on Debt Segment and Capital Market Segment of National Stock Exchange (‘NSE’) and BSE, respectively. The Meeting of Administrative Committee of the Board of Directors held on September 20, 2022 approved the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.